Brimonidine Tartrate* — Medicare Part D Spending

Generic: Brimonidine Tartrate | Manufacturer: Overall

2023 Spending

$88.9M

2023 Claims

2,067,507

2023 Beneficiaries

573,214

Cost/Unit (2023)

$4.14

5-Year Spending Trend (2019-2023)

Year	Total Spending	Claims	Beneficiaries	Cost/Unit
2019	$103.1M	1,759,071	430,999	$6.32
2020	$97.7M	1,768,903	441,198	$5.76
2021	$94.9M	1,802,673	477,037	$5.45
2022	$86.3M	1,882,669	512,550	$4.69
2023	$88.9M	2,067,507	573,214	$4.14

5Y CAGR (cost/unit): -10.0%YoY Change (2022-2023): -11.7%

📊

DrugPricePeek Editorial TeamData Specialists

The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.

✓ Sourced from CMS NADAC & Medicare Part D✓ Quarterly review✓ No paid placements

Read our full methodology or contact us with corrections.

Frequently Asked Questions

How much does Medicare spend on Brimonidine Tartrate*?

In 2023, Medicare Part D spent $88.9M on Brimonidine Tartrate* (Brimonidine Tartrate), serving 573,214 beneficiaries across 2,067,507 claims.

What is the cost per unit of Brimonidine Tartrate* under Medicare?

The weighted average cost per dosage unit of Brimonidine Tartrate* was $4.14 in 2023. The 5-year compound annual growth rate (2019-2023) was -10.0%.

Who manufactures Brimonidine Tartrate*?

Brimonidine Tartrate* (generic name: Brimonidine Tartrate) is manufactured by Overall. There are 9 manufacturer(s) listed in the CMS database for this drug.

Is Brimonidine Tartrate* covered by Medicare Part D?

Yes, Brimonidine Tartrate* is included in Medicare Part D spending data, indicating it is covered by Part D plans. However, specific coverage and tier placement vary by plan. Check with your specific Part D plan for formulary details.

Where does this Medicare spending data come from?

All Medicare Part D spending data comes from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Spending by Drug dataset, which is publicly available at data.cms.gov.

Explore the DataPeek Network

MedCheckWize MedCostPeek CareFindPeek BreathePeek VetCostPeek VocabWize VocabLibre DicionarioWize WortWize KalimaWize KotobaPeek NameBlooms WagePeek NetPayPeek SalaryByCity CostByCity

Year

Total Spending

Claims

Beneficiaries

Cost/Unit

2019

$103.1M

1,759,071

430,999

$6.32

2020

$97.7M

1,768,903

441,198

$5.76

2021

$94.9M

1,802,673

477,037

$5.45

2022

$86.3M

1,882,669

512,550

$4.69

2023